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Summary 
The orphan receptor Dax-1 is highly expressed in pluripotent embryonic stem (ES) 
cells and shows a correlative reduction in expression as these cells differentiate. 
While it is known that Dax-1 is expressed in pluripotent mouse ES cells, the precise 
function of Dax-1 in these cells is not as well understood. Recent studies employing 
RNA interference (RNAi) to specifically reduce the expression of the Dax-1 gene in 
mouse ES cells found that upon the knock down of Dax-1, ES cells differentiated. 
These findings indicate that Dax-1 functions in a novel role in the maintenance of a 
relatively undifferentiated state in ES cells. 
Dax-1 is important in early embryonic development and, when mutated, adrenal 
insufficiency and disruption of normal tissue architecture results. In our study, we 
silenced Dax-1 expression in mouse ES cells using RNAi followed by PCR array 
methodology to identify genes that were alternately regulated upon targeted knock-
down of Dax-1. Several novel Dax-1 targets have been identified, including genes 
that are involved in the Wnt signaling pathway. In attempts to understand the 
mechanism of Dax-1 action in ES cells, we are investigating the effect of Dax-1 
knockdown on the regulation and expression of the identified target genes.  
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 6 
Introduction 
Chapter 1: Transcriptional Regulation of Pluripotency and Differentiation 
Embryonic Stem Cells and Development of Mammals 
Embryonic Stem Cells (ESC) are a unique population of cells in that they have 
the ability to maintain self-renewal, remaining in an undifferentiated state. At 
appropriate times of proliferation, they differentiate from their multipotent status 
into virtually any cell type in the body (Okita and Yamanaka 2006). Primitive cells, 
derived from the inner cell mass (ICM) of the blastocyst, have the ability to self-
renew and possess molecular mechanisms to become any cell type in a whole 
mammalian embryo (Clevers 2005). In the case of when a mammalian embryo is 
fertilized, it undergoes several rounds of cell division in embryogenesis where one 
cell becomes two and two becomes four, etc. About three days after fertilization 
these early precursor cells of developing human and mice differentiate into a 
morula, or a solid collection of 16 totipotent cells (Figure 1). As the mammalian 
embryo continues to develop, cells of the morula will continue to self-renew through 
several rounds of cleavage, and on the 4th-5th day post fertilization differentiate 
into a blastocyst of 2 distinct embryonic stem cell types; an inner layer of cells 
forming the pluripotent inner cells mass surrounding a blastocoel that will 
differentiate into the embryo and an outer layer of cells that form the trophoblast 
and will go on to form the placenta that will invade uterine tissue and implanting 
the blastocyst (Gilbert 2006). From the inner primitive cell layers of the ICM, three 
distinct embryonic tissue layers, the ectoderm, mesoderm, and endoderm of the 
blastocyst form, all of which will eventually differentiate to distinct cell  
 Figure 1. Mammalian Embryonic Stem Cells.
egg, the cells of the first 4 cleavages
capable of differentiating into a whole mammal. The Blastocyst contains an inner 
cells mass of pluripotent stem cells that can give rise to
multiple tissue types comprising an mammal. 
(Imagehttp://upload.wikimedia.org/wikipedia/commons/thumb/3/3c/Stem_cells_
diagram.png/400px-Stem_cells_diagram.png
 
 
 
 Upon fertilization of a sperm and 
 that form into the morula are totipotent, 
 unipotent precursor cells of 
 
) 
7 
 
 8 
fates throughout the developmental process (Niakan 2006). It is from these inner 
mass cells that embryonic stem cells are excised, dissociated, and immortally 
maintained in culture for their use in mammalian developmental research (Zalzman 
2010).  
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Pluripotency 
In mammals, early embryonic development from a fertilized cell into blastocyst of 
about 100 embryonic stem cells is a highly regulated process controlled by 
transcription factors that act in a very specific, subtle, and profound fashion. Many 
of these gene regulators orchestrate the chemical events where they function to 
dictate and regulate differentiation in early development, but there are a select few 
key transcription factors that function to modulate transcriptional networks that 
from a downstream perspective, control cellular activity and metabolism such as 
maintaining pluripotency in ESCs. ( Wang 2006).  Nanog, Oct3/4, and Sox2 are all 
transcription factors with distinct DNA Binding Domains (DBDs) that are essential 
in regulating this process of self-renewal seen in pluripotent cells (Figure 2). These 
very important transcription factors are conserved in mammalian development and 
each have distinct chemical lineages. Nanog is a nuclear homebox protein that 
contains a domain that functions in binding to homeodomain DNA elements so that 
transcriptional control can be exerted. Oct3/4, or POU5F1, is a octomer-binding 
transcription factor of the POU family that also contains a domain for binding to 
POU DNA elements. Loss of either Nanog or Oct4 results in immediate loss of 
pluripotent potency in ESCs (Loh 2006)  
Lastly, Sox2 is a transcription factor that also functions to maintain stem cell 
pluripotency. The HMG box protein is encoded from an SRY related gene and 
functions in binding to High-Motility Group DNA elements to employ its 
transcriptional control (Rizzino 2009).  
   
 
 
Figure 2. Pluripotency Transcription Factors.
different domains in the transcription factors Nanog, Oct4, and Sox2. Domains 
depicted in green represent the region of the protein that binds to DNA response 
elements. B. Pluripotency factors interact with one another to dri
gene activation. Pluripotency driving transcription factors also negatively regulate 
differentiation with the interaction of co
Mol Life Sci. Nov;66(21):3403
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It has been shown that Nanog is a master regulator of pluripotency and has 
affinity in interacting with proteins such as Oct4 and Sox2, as well as itself in large 
transcriptional complexes. These major regulators are essential for populating the 
inner cell mass of the blastocyst with cells that have the capability of pluripotency 
and are able to self renew. What remains fascinating about these key regulators is 
that if the concentration of these factors is pushed beyond a precise, small window 
of activity, their ability to function in the maintenance of self-renewal and 
pluripotency is lost. Further, if the expression of these key transcription factors is 
up-regulated, perturbed, or lost within ESC, the mechanism to maintain 
pluripotency is also lost, and ESC differentiate (sometimes prematurely) (Loh 
2006). Because of the potential of stem cell based therapies in many cases of 
disease, the need to decipher the mechanism of action involved these highly 
complex networks involved in maintaining pluripotency and driving differentiation 
is becoming increasingly important and currently is still an unsolved puzzle in stem 
cell biology.  
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Nuclear Receptors and Transcriptional Regulation in Development 
 Another group of transcription factors that play a major role in stem cell 
biology are the Nuclear Hormone Receptors (NHRs). Nuclear Hormone Receptors 
comprise a very large and diverse class of proteins that mainly function within the 
nucleus as transcription factors in either direct or indirect regulation of gene 
expression (Figure 3). Precise and particular expression events are maintained 
largely by NHR activity in early embryonic development. Mainly these proteins 
function by sequence-specific mechanisms in the nucleus to maintain overall cell 
physiology and dictate fate processes such as self-renewal or differentiation. (Parks 
2005)  
 Further, proteins that are classified as Nuclear Hormone Receptors are very 
similar to many transcription factors, like Nanog and Oct4, in that they contain a 
distinct N-terminal DNA Binding Domain (DBD); but what makes them unique in 
their protein structure is that they contain a C-terminal Ligand Binding Domain 
(LBD) in addition to their variable N- and C-terminal regions. In transcription 
factors and NHRs, these key motifs are conserved features of evolution where both 
the DBD and LBD contain regions of specific amino acids that are necessary for 
these molecules to function. Often, motifs of the DNA binding domains are observed 
similarly in transcription factors and NHRs.  Like the homeo- and POU domains of 
Nanog and Oct4, respectively, NHRs have been observed to have 2 cysteine rich zinc 
finger motifs in their DBD, which mediate binding of the protein to zinc finger 
response elements through the coordination of Zinc ions between the protein and  
  
 
Figure 3: Nuclear Hormone Receptor Structure. 
structure of a Nuclear Hormone Receptor.
domains in NHRs such as the DNA Binding Domain and Ligand Binding Domain as 
well as the hinge region. 3D image from X
directly binds to DNA through DBD as well as how the NHR is activat
binding. ( Images from http://medlibrary.org/medwiki Nuclear_hormone_receptor
 
 
 
 
Diagram showing the typical 
 1D image shows conserved critical 
-ray crystallography depicts how NHR 
ed upon ligand 
13
) 
 14
the DNA, which helps build stability in transcriptional complex formation 
(Manglesdorf 1995). 
 In addition to unique DBD domains necessary for NHR function, NHR proteins 
contain a Ligand Binding Domain in their structure that often has sequence affinity 
for binding a ligand, such as a lipophilic hormone. NHRs bind to their appropriate 
DNA response elements upon binding of a ligand to activate the NHR.  Specifically, in 
the molecular events of steroid NHR activation, a steroid hormone binds to the LBD 
of its cognate NHR (such as estrogen binding to estrogen receptor), which triggers a 
conformational change in the NHR resulting in a structure that is available for 
interacting with transcriptional machinery (Suzuki 2003). The regulation and 
formation of large transcriptional complexes is a very important process of gene 
regulation in development as well as overall cell physiology. For example, in the 
development of gonad tissues, transcriptional complexes are formed and directed 
by hormone regulation of testosterone and estrogen and response of their 
respective NHR action (Cooney 2003).  
  One of the subgroups within the Nuclear Receptor Family are the Orphan 
Nuclear Hormone Receptors, which have structural similarity to NRs but function 
without the known need of a ligand. (Sablin 2008) Several orphan receptors such as 
SF1, ERR, and Dax-1, have been shown to be necessary for proper embryonic 
development (Cooney 2003).   
 Dax-1  (Dosage- sensitive sex reversal and adrenal hypoplasia congenita on the 
X chromosome gene 1) is a unique orphan NHR that is encoded by the NR0B1 gene. 
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This gene encodes the roughly 550 amino acid long Dax-1 protein (Figure 4.A.), and 
it corresponds to the 2 exon regions that encode the DBD and LBD (McCabe 2000). 
 Further, a splice variant of Dax-1 (Dax-1A), which contains a truncated LBD, 
has also been discovered recently and its expression is equally distributed among 
many tissues and its function is similar to Dax-1 (Niakan and McCabe).  Structurally, 
Dax-1 is homologous to other NHRs; however, it has a few unique features. The DBD 
contains 3 conserved repetitive regions of LXXLL motifs (L = Leucine and X = any 
amino acid) that are necessary for interaction with other Nuclear Receptors (Figure 
4.B.). Dax-1 is also a unique orphan NHR, in that the amino acid residues that would 
characteristically encode the ligand binding pocket of a LBD of a typical NR contain a 
unique insertion that forms a region that is physically too small to bind a 
hypothetical ligand (Figure 4.C.), and also this region is poorly conserved among 
species. This indicates evidence for the lack of a specific ligand for Dax-1 as well as 
highlights that Dax-1 is a very old Nuclear Receptor that likely has a homolog role in 
many vertebrates (Sablin and McCabe).  
 In general, NHRs function by either repressing or activating transcription of 
specific target genes. Orphan receptors are molecules that have been shown to 
function both as activators and repressors in the context of development also in the 
context of which factors they are interacting with at a given transcriptional event 
(Kim 2008). For example, in the development of steroidogenic tissue, SF-1 (another 
NHR that is also classified as an orphan receptor) and Dax-1 have been shown to be 
present and interacting in developing testis (Hammer 1999).  
 Figure 4: NR0B1 gene encodes Dax
Depiction of the NR0B1 gene located on the X chromosome which encodes the Dax
protein. 1D image of protein shows conserved NHR DNA Binding Domain and 
Ligand Binding Domain with 3 arrows in the DBD indicating 3 unique regions of 
LXXLL motifs in Dax-1’s DBD. B. Dax
transcriptional complexes with other co
Dax-1 functions by interacting with AF
1) bound to DNA. This is indicated by LXXLL in black and AF
crystallography structure of Dax
through LXXLL motif. (Images from Niakan KK, McCabe ER: DAX1 origin, function, 
and novel role. Mol Genet Metab 2005, 86(1
http://en.wikipedia.org/wiki/DAX1
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These two orphan receptors have also been shown to function in the regulation of 
the expression of each other. In the developing testis and in adrenal cortex, it has 
been shown that SF-1 positively regulates Dax-1 expression. Once the proteins 
levels of Dax-1 reach a steady state in these developing tissues, Dax-1 functions to 
repress SF-1’s protein activity so that there is not an over-expression of Dax-1. This 
level of regulation is called feedback inhibition. (Kim 2008). Dax-1 represses SF-1’s 
activity by binding to and inhibiting SF-1 through direct protein-protein 
interactions. Dax-1 coordinates with SF-1 through the N-terminal LXXLL motifs as 
well as recruits other co-repressors, such as Nuclear Co-repressor (NCoR), to the 
LBD, so that overall Dax-1 expression is inhibited (Hoyle 2002).  
 The mechanism of transcriptional repression or activation is often dictated by 
the levels of the respective proteins that are present within the cell as well as the 
cofactors with which they are interacting. The maintenance of a steady state 
concentration for Nuclear Hormone Receptors such as Dax-1 or SF-1 is key for 
proper development to occur (Wood and Hammer 2011). If either Dax-1 or SF-1  is 
over-expressed in vitro, or duplicated on their respective chromosome in vivo, 
developmental defects result. These include for Dax-1, dosage sensitive sex reversal 
where gonadal development is sex reversed or adrenal hypoplasia congenita (AHC) 
where dysplastic tissue develops in place of normal testis or adrenal cortex 
(Hammer 2005). It has also been shown that deficiency of Dax-1 in mice results in 
improper steroidogenesis and adrenal cortical development (Hammer 2011). In 
human patients, mutations in the C terminal region of Dax-1 result in abnormal 
adrenal phenotypes where the outer layer of the adrenal cortex fails to form 
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properly. Additionally, there is an absence of normal corticosteroid hormone 
synthesis, along with hypogonadotropic hypogonadism in the pituitary and 
hypothalamus. Unless hormone replacement therapy is begun, these mutations can 
be lethal. This further indicates the importance of understanding the critical 
windows of molecular events of both Dax-1 and SF-1 in order to better understand 
early embryonic development and maintenance of steroidogenic tissue (Reutens 
1999).  
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The Role of Dax-1 in Embryonic Development 
Recently, it has been shown that Dax-1 expression is essential for the 
maintenance of pluripotency in mammalian embryonic development. Dax-1 has long 
been established as a potent regulator a steroidogenesis, but only within the last 
decade has its role been extended into a developmental context. In the early 
cleavages of murine embryogenesis, Dax-1 expression is prolific. As early as the 8-
cell stage, Dax-1 is widely expressed (Niakan 2006). Intriguingly, many of the factors 
that Dax-1 regulates in the context of steroid hormone synthesis are not present at 
these early stages of development hinting that Dax-1 is functioning in a role 
separate from steroidogenesis (Niakan 2006).  In other studies, targeted knockdown 
of Dax-1 by RNAi in mouse embryonic stem cells has resulted in pre-mature 
differentiation indicating that Dax-1 has a role in maintaining stem cell pluripotency 
(Khalfallah 2009). Further, Dax-1 appears to be a part of a larger transcriptional 
network that maintains pluripotency indicative by the factors that regulate its 
expression. As previously mentioned, the transcription factors Nanog and Oct3/4 
are both factors that maintain pluripotency, and they both have been shown to 
function to bind to specific response elements on the DNA and have positive 
regulation on the Dax-1 promoter. Central to this, it has been shown that as little as 
500 base pairs of the Dax-1 promoter are necessary for activation of Dax-1 by 
Nanog. Through co-immunoprecipitation assays, it has been shown that the Nanog 
protein directly binds to Dax-1 promoter and, while interacting with co-activators, 
positively drives Dax-1 expression thus maintaining embryonic stem cell 
pluripotency (Hammer 2011). 
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 Physiologically, Dax-1 has been shown to be a critical regulating factor of 
development and function for both the hypothalamic-pituitary-adrenal (HPA) and 
hypothalamic-pituitary-gonadal axis (Hammer 2011). Moreover, Dax-1 has been 
shown to play a role as an anti-testes gene in its repression of SRY by repressing 
SOX9 thereby allowing SRY to be active and orchestrate testes development    
(Figure 5) (Goodfellow 1999). When Dax-1 is overly expressed in males, and it is not 
very well understood why this happens, a XY female sex reversal phenotype is seen. 
In other words, the XY individual underwent female reproductive differentiation 
(Wilheim 2007). Without another X for X inactivation,  these XY individuals develop 
with disruption of dosage sensitivity of Dax-1, and this abundance of Dax-1 
improperly represses SRY in these males resulting in a sex reversal phenotype 
(Ludbrook 2004). The duplication mutation does not appear to have any effect on 
females and, if anything, evidence demonstrates Dax-1 may be involved in oocyte 
development as disruption does not result in loss of normal sex maturation, 
ovulation, and fertility. The only abnormality found is that mutant Dax-1 females 
had an abnormal number of oocytes in one follicle (Hsieh 2002).  
 In the mouse, sole duplication of this phenotype does not result in sex reversal, 
but it does show delayed/abnormal testes development. In the transgenic mice, 
abundance of Dax-1 prevents the Sertoli and Leydig cells from differentiating 
properly (Haley 2000). When mice over-expressing Dax-1 were crossed with mice 
that had weakened SRY, the XY offspring mice developed complete male to female 
sex reversal. This demonstrates that in the divergence from mice, there are  
  
Figure 5:  Dax-1 expressed in Early Embryonic Development. 
antibodies stains for Dax-1. These figures indicate that Dax
red) is present as early as the 8 cell stage and persists through blastocyst formation. 
In this context, Dax-1’s expression is not turned off until pluripotent embryonic 
germ layers begin to differentiate. Panels F and H serve as contr
blastocyst formation and panel G is stained for a Dax
for the secondary antibody used in this analysis. 
Niakan, E. C. D., Robert C. Clipsham, Meisheng Jiang, Deborah B. Dehart e, 
K. Sulik, Edward R.B. McCabe (2006).) 
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differences in the events of sex determination in human embryonic development 
(Goodfellow 1999). In addition to unique sexual phenotypes that result from 
abnormal Dax-1 expression, transgenic Dax-1 knock out mice develop with hyper-
amplified adrenal activity until the tissue began to age prematurely whereas in 
humans, upon loss of Dax-1, only hormone replacement therapy will rescue viability 
(Hammer 2011). 
 Dax-1’s role in steroid hormone synthesis and sex determination has been 
established and validated in both mice and humans. Intriguingly, it has been found 
that in mouse development, Dax-1 has been shown to be a negative regulator of 
differentiation in pluripotent stem cells (McCabe 2006). In the developing embryo, 
Dax-1 has been shown to have cytoplasmic expression at the 8-cell stage and 16-cell 
stage morula (E2-3.5). As the blastocyst stage progresses in development, Dax-1 
localizes to the nucleus (E4) (Niakan 2006). This data shows that Dax-1 is a good 
marker for predicting early axis development (Figure 5). It has also been shown that 
Dax-1 is ubiquitously expressed in all three embryonic tissue layers. However, as 
the three layers each differentiate, Dax-1 expression is down regulated, and 
transiently up-regulated in differential patterns (Niakan 2006). Both Dax-1 and its 
splice variant (Dax-1A) have been identified in these early cell stages and seem to be 
actively functioning. It also appears that Dax-1 and Dax-1A’s function is different 
from the known and validated steroidogenic role of Dax-1 (McCabe 2006). Many of 
the partners Dax-1 interacts with in steroidogenesis, such as SF-1, are not present 
when Dax-1 is expressed in these early embryonic tissues, indicating that Dax-1        
 23
 has a role different from steroidogenesis in developing embryonic tissues (Niakan 
2006). 
  Molecular evidence indicates that in early development, Dax-1 is maintaining 
pluripotency by repressing critical genes involved in differentiation. In has been 
shown that Dax-1 directly interacts with transcription factors, such as Nanog and 
Oct3/4, that regulate pluripotent status (Hammer 2011). At some point during this 
self-renewal process, Dax-1 receives a signal to be down regulated, which frees 
critical differentiation genes to become activated and drives those cells through 
differentiation. These results indicate that Dax-1 is a part of a complex 
transcriptional network receiving many inputs and signals to result in normal 
embryonic development. The precise mechanism of how Dax-1 functions in this 
highly complex network that maintains pluripotency remains a very elusive topic. 
However, in some developmental contexts it has been shown that Dax-1 is regulated 
by specific signaling factors.   
 There are many signaling pathways that function in early embryonic 
development.  One that specifically is conserved across many developmental 
contexts is the Wnt signaling pathway (Figure 6). This cellular signaling pathway 
functions by binding an extracellular Wnt ligand to signal intracellularly and 
activate a major effector transcription factor, beta-catenin (Kim 2009).  Recently, its 
been shown that in the female developing gonad, Dax-1 is positively regulated by 
Wnt4 (Jordan 2001). Studies have shown that when Wnt4 is activated, beta-catenin   
 
  
Figure 6: Wnt Signaling Pathway. 
development where a secreted Wnt ligand binds to a cell surface receptor called 
Frizzeled. Binding of Wnt to this GPCR activates an intracellular cascade of events 
that results in inhibition of a kinase called GSK
Wnt effector molecule, Beta
degradation but instead is free to localize in the nucleus and affect gene regulation. 
(Image from McDonald et al., Dev Cell. 2009 Jul; 17(1):9
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has been found to localize at the Dax-1 promoter and activate its transcription 
(Mizusaki 2003). In the male developing gonad, Wnt4 signaling is decreased and 
thereby decreasing Dax-1 expression. Looking back to male gonad development, 
decrease of Dax-1 results in a rise of SRY peaks due to unrepressed SOX9 function. 
Further, in the absence of Dax-1, male determination factors such as MIS are 
unregulated to promote appropriate testes differentiation (Wilheim 2007). 
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Transcriptional Regulation of Differentiation 
 Pluripotency is a highly regulated process maintained by a specific set of 
factors, as are the events of differentiation in cell fate specification and 
determination during mammalian embryogenesis. As the mammalian blastocyst 
forms and differentiates, a multitude of transcriptional activities continues. In E9 of 
murine development (equivalent to the 4th week of human development), 
multipotent cells of the coelomic epithelia in the blastocyst begin to express SF-1. 
This factor is highly expressed during the differentiation of these mesoderm-derived 
cells into steroidogenic adrenogonadal precursor cells that will ultimately go on to 
become cells of the gonads and the adrenal gland (Hammer 2012). As these 
primordial cells continue to develop, much transcriptional regulation will occur to 
facilitate the differentiation of adrenal and gonadal tissue from undifferentiated 
cells of the mesoderm. Along with SF-1, another key transcription factor that 
regulates the differentiation from mesoderm into adrenogonadal progenitor cells is 
another orphan Nuclear Hormone Receptor, Liver Receptor Homolog 1 (LRH-1). In 
this developmental context, SF-1 and LRH-1, regulated by Dax-1, act as activators of 
transcription to drive the development of adrenal and gonadal tissue (Yazawa 
2011). In mouse embryonic stem cells, LRH-1 has been shown to function as an 
activator of Oct4 expression though interaction with beta-catenin to synergistically 
drive self-renewal and proliferation. However, upon endoderm tissue 
differentiation, LRH-1 expression is turned on along with other orphan receptors 
such as SF-1 and Dax-1 to maintain and regulate the development of endoderm 
lineage tissue as well as steroidogenesis (Cooney 2007). 
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Research Proposal 
 Given convincing preliminary evidence that Dax-1 expression maintains 
embryonic stem cell pluripotency, this thesis will further investigate the precise role 
of Dax-1 in carrying out this mechanism. As a Nuclear Receptor, Dax-1 functions to 
transcriptionally regulate target genes by interacting with many other nuclear 
receptors in the formation of large transcriptional complexes. It is the goal of this 
research is to determine the exact target genes of Dax-1 in mouse embryonic stem 
cells. Khalfallah et al showed that targeted knockdown of Dax-1 by siRNA leads to 
differentiation of embryonic stem cells indicated by fate-specific gene up-regulation 
(Khalfallah 2009). To determine precisely the physiologically relevant target genes 
of Dax-1 in pluripotent embryonic stem cells, I aim to selectively knockdown Dax-1 
using siRNA technology. Targeting three critical regions in Dax-1 transcript should 
activate cellular destruction of Dax-1 mRNA. As Dax-1 is a known transcriptional co-
repressor, the absence of Dax-1 should free transcriptional control of differentiation 
genes and lead to their up regulation upon the loss of pluripotency by Dax-1 
knockdown. 
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Methods and Materials 
Cell Culture 
Mouse embryonic stem cells (mESC) (donated from Mohammed D., Collaborator at 
Dominican University, Marin, CA) were routinely passaged, cultured, and 
maintained at 37°C in a humidified 5% carbon dioxide tissue culture incubator. 
mESC were cultured in Dulbecco’s modified eagle medium (DMEM) and Ham’s F12 
(1:1) with phenol red and additionally completed and supplemented with 10% Fetal 
Bovine Serum (ATCC, Manassas, VA), 1% L-Glutamine (Invitrogen, Carlsbad, CA), 
1% Penicillin/streptomycin (Invitrogen, Carlsbad, CA), and 1% Fungizone 
(Invitrogen, Carlsbad, CA). To maintain and passage mESC, cells were washed with 
phosphate buffered saline (PBS) and treated with 2 milliliters (mL) of 0.125% 
Trypsin (ATCC, Manassas, VA) for removal from flask and resuspended with 8mL of 
complete DMEM. Cells were passaged in a 1:10 ratio. 
siRNA Transfection 
Three synthetic double-stranded siRNA oligonucleotides selective for Dax-1 were 
selected based on efficient knockdown observed by Khallaflah in 2009 (Table 1).  
The medium GC Stealth oligonucleotides was used a control. siRNA oligonucleotides 
for Dax-1 were  transfected into mESCs seeded at a volume of 1x105 cells per well in 
12- well plates using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA)  according 
to the manufacturer's protocol. mESC were transfected for 24 hours and transfected 
again using the same protocol for an additional 24 hours for a total of 48 hour siRNA  
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Table 1: small interfering RNA (siRNA) targeting Dax-1 mRNA transcript. 
Depicted are the sequences of Stealth RNA used in siRNA transfections of mESC. 
RNA exists in duplex because it ensures higher fidelity in knocking down the target. 
Duplex strands of RNAi tag mRNA of Dax-1 to associate with RISC complex in order 
to break down mRNA of Dax-1 and inhibit protein synthesis of Dax-1. One duplex 
targets the DBD while the other two duplexes target the LBD of the Dax-1 mRNA 
transcript.  
 
 
 
siRNA Duplex Strand Targets 
Dax-1 siRNA#1         CAG UGG CAG GGC AGC AUC CUC UAC 
A 
       GUC ACC GUC CCG UCG UAG GAG AUG U 
DNA 
Binding 
Domain 
Dax-1 siRNA#2        UUA AGU UCG AUG AAU CUG UCA UGG G 
         AAU UCA AGC UAC UUA GAC AGU ACC C 
Ligand 
Binding 
Domain 
Dax-1 siRNA#3       UCG GCA CAG UCA GCA UGG AUG AUA U 
     AGC CGU GUC AGU CGU ACC UAC UAU A 
 
Ligand 
Binding 
Domain 
 
 
 
 
 
 
 
 
treatment. Following 48 hour double transfection treatment, total RNA and whole 
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cell protein lysates were collected for further analysis. 
RNA Isolation 
Total RNA was collected following 48 hour siRNA transfection using the RNAeasy 
miniprep kit manufacturer's protocol (Qiagen, Valencia, CA). In brief, the collection 
was performed as follows. Prior to RNA collection, untreated and treated mESC 
were trypsinized and collected into a 1.5mL microcentrifuge tube. The cells were 
then spun and pelleted at 1000 x g for 5 minutes. While cells were cell pelleting, 
equilibration of RLT buffer (RNA lysis buffer) with 1% beta-mercaptoethanol ( -
ME) was performed. After aspirating media supernatant from pelleted cells, cells 
were then washed with 1X PBS, and then spun for 5 minutes at 1000 x g. Washed 
cell pellet was then treated with 300 microliters (uL) of RLT +  -ME to disrupt cell 
pellet. The sample was then vortexed for 10 seconds, and then lysate was passed 
through a 18 gauge needle attached to a 3cc syringe at least 10 times to homogenize 
lysate. 300 microliters of 70% Ethanol (EtOH) was then added directly into 
homogenized lysate. After resuspending lysate thoroughly, the sample was then 
transferred to a clean RNAeasy mini column in a 1.5mL centrifuge tube. RNAeasy 
mini column was then centrifuged at 8000 x g for 15 seconds. After discarding the 
supernatant, the column was washed with 700uL of RW1 buffer and then spun at 
8000 x g for 15 seconds. After discarding supernatant, the column was then washed 
with 500uL of RPE buffer and centrifuged at 8000 x g for 45 seconds twice. After 
discarding the supernatant and transferring the column to a clean 1.5mL RNAase 
free microcentrifuge tube, 40-50uL of RNAase free water was directly applied to the 
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column for a 1 minute incubation at room temperature. RNAeasy column + clean 
microcentrifuge tube were then centrifuged at 8000 x g for 15 seconds to collect 
total RNA. Purity of RNA was then measured using a Nanodrop spectroscope to 
determine the concentration of the sample for further cDNA synthesis and analysis.  
cDNA Synthesis 
cDNA was synthesized using 1ug of RNA from untreated and treated mESC. mESC 
cDNA was synthesized using RT- First Strand kit (SA biosciences). In brief, the 
synthesis was performed as follows. After thawing reagents from kit in a bucket of 
ice, RNA samples were then treated with 2uL of Buffer GE + RNAase free water and 
incubated at 42°C for 5 minutes to eliminate genomic DNA. After incubations, 
samples were immediately placed on ice for 1 minute. Subsequently, samples were 
treated directly with 4uL of Buffer BC3 + 1uL Control primer P2 +  2uL RE3 Reverse 
Transcriptase + 3uL of RNAase free water to bring a total volume of synthesis 
sample to 20uL. Reverse transcription was then performed using the BioRad MJ 
mini ThermoCycler machine (BioRad, Hercules, CA). The samples were incubated 
through one cycle in the machine at 25°C for 5 minutes, 42°C for 15 minute,s 
followed by 95°C for 5 minutes to denature the reverse transcriptase enzymes. 
Samples were then maintained at a 4°C hold. After protocol has run, samples were 
then directly diluted with 30uL of RNAase free water to bring a total 50uL cDNA 
synthesis sample that will be further analyzed by regular PCR, qPCR, and qRT-PCR 
arrays. 
Regular PCR and qPCR analysis 
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To detect and quantify expression of Dax-1 as well as its candidate target genes, 
untreated and treated mESC cDNA was compared and relative gene expression was 
measured using two PCR analysis methods: regular PCR and quantitative PCR. 
Primers for Dax-1, GAPDH, and candidate target genes were ordered from 
Integrated DNA Technologies for this analysis (Table 2).  
For regular PCR, each sample was prepared with 10uL of 2X GoGreen (Promega, 
Madison, WI) or with 9.5uL  FailSafe PCR premix G + .5uL FailSafe Enzyme mix 
(Epicentre, Madison, WI), 0.25uL forward primer, 0.25uL reverse primer, 7.5uL of 
nuclease free water, and 2uL of  cDNA. PCR was then performed using the MJ mini 
ThermoCycler (BioRad, Hercules, CA) following the same PCR protocols with 
slightly varying annealing temperatures (Table 2). The template PCR protocol used 
was one cycle of 95°C for 4 minutes; 29 cycles of 95°C for 25 seconds, 55°C for 30 
seconds, 72°C for 30 seconds; one cycle of 72°C for 5 minutes; and concluding with a 
4°C hold for forever. After PCR run, samples were then electrophoresed on a 1.5% 
agarose gel containing ethidium bromide and visualization of the gels was 
performed on the BioRad GelDoc System (BioRad, Hercules, CA) using Ultraviolet 
light.  
Quantitative PCR analysis was performed on untreated and treated mESC cDNA to 
analyze the relative gene expression of Dax-1 compared to GAPDH expression using 
the MyIQSingle Channel RT-PCR system (BioRad, Hercules, CA) using SYBR Green I 
dye (BioRad, Hercules, CA). Samples were prepared with 12.5uL SYBR Green,    
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Table 2: Mouse DNA Primers used in PCR and qPCR analysis. This list specifies 
the primers and parameters used to further analyze Dax-1, GAPDH, and candidate 
target genes’ expression in mouse embryonic stem cells. 
 
Target 
Name 
Fwd Primer 5’->3’ Rev Primer 5’->3’ Annealing Temp  
mDax-1 TCC TGT ACC GCA 
GCT ATG TG 
TCG AAG TGC AGG 
TGA TCT TG 
54°C 
mGAPDH ACA GCC GCA TCT 
TCT TGT GCA 
GGG CTT GAC TGT 
GCC GTT GAA 
54-57°C 
mAfp AGC AAA GCT GCG 
CTC TCT AC 
GAG TTC ACA GGG 
CTT GCT TC 
55°C 
mGbx2 GGC AAC TTC GAC 
AAA GCC GAG 
CCA GGC AAA TTG 
TCA TCT GAG 
55°C 
mGata6 ATG CTG TCC GGC 
CTG CCC TA 
GTT CAC GCA CTC 
GCG GCT CT 
60°C 
mNanog GCA GCC AGA CCT 
GGA CCA ACC 
CAG CAT TCC AAG 
GCT GGC CG 
60°C 
mSox-17 TTG GCC  CCA ACA 
CTC CTC CCA 
CTG CTA TGG CCA 
CGG GAC ACG  
60°C 
mSox-2 AGG AGT TGT CAA 
GGC AGA GAA 
GCG TCT TGG TTT 
TCC GCC GC 
58°C 
mT-
Brachyury 
GGA ACC ACC GGT 
CAT CGC CC 
CAG CCC GTT GGA 
CAC CCC AG 
60°C 
 
 
 
 
 
 
0.25uL forward primer, 0.25uL reverse primer, 9uL nuclease free water, and 3uL of 
cDNA. All samples were prepared in triplicate. Results were analyzed using the 
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MyIQ software (BioRad, Hercules, CA) as well as Microsoft excel.  
qRT-PCR Arrays  
cDNA synthesized from mouse embryonic stem cell RNA was used to analyze 
differential gene expression of two signaling pathways, the mouse embryonic stem 
cell signaling pathway and the mouse Wnt signaling pathway, in stealth control 
treated mESC and siDax-1 treated mESC (SAbiosciences, Frederick, Maryland). To 
analyze gene expression in these pathways, real time quantitative PCR analysis was 
performed using the RT Profiler PCR Array System (SAbiosciences, Frederick, 
Maryland). The array plates for each pathway contained 84 different genes found in 
each respective pathway and also 5 housekeeping genes and contamination controls 
(Tables 3 and 4). The PCR plates were run using the CFX96 Real-Time System cycler 
(BioRad, Hercules, CA), following a superarray two-step cycling PCR protocol where 
each plate ran one cycle for 10 minutes at 95°C, as well as 40 cycles of 95°C for 15 
seconds and 60°C for 1 minute. After superarray protocol was run for each plate, 
RT-PCR data analysis was performed using the website: 
http://www.SABiosciences.com/pcrarraydataanalysis.php  to compare gene 
expression of stealth control treated mESC samples and siDax-1 treated mESC 
samples (SAbiosciences, Frederick, Maryland).  
 
 
Table 3: Genes in the Mouse Embryonic Stem Cell Signaling Pathway 
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Gene Symbol Gene Description 
Afp Alpha fetoprotein 
Brix1  BRX1, biogenesis of ribosomes, homolog (S. 
cerevisiae) 
Cd34  CD34 antigen 
Cd9  CD9 antigen 
Cdh5  Cadherin 5 
Cdx2  Caudal type homeobox 2 
Col1a1  Collagen, type I, alpha 1 
Commd3  COMM domain containing 3 
Crabp2  Cellular retinoic acid binding protein II 
Ddx4  DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 
Des  Desmin 
Diap2  Diaphanous homolog 2 (Drosophila) 
Dnmt3b  DNA methyltransferase 3B 
Ednrb  Endothelin receptor type B 
Eomes  Eomesodermin homolog (Xenopus laevis) 
Fgf4  Fibroblast growth factor 4 
Fgf5  Fibroblast growth factor 5 
Flt1  FMS-like tyrosine kinase 1 
Fn1  Fibronectin 1 
Foxa2  Forkhead box A2 
Foxd3  Forkhead box D3 
Gabrb3  Gamma-aminobutyric acid (GABA) A receptor, subunit 
beta 3 
Gal  Galanin 
Gata4  GATA binding protein 4 
Gata6  GATA binding protein 6 
Gbx2  Gastrulation brain homeobox 2 
Gcg  Glucagon 
Gcm1  Glial cells missing homolog 1 (Drosophila) 
Gdf3  Growth differentiation factor 3 
Grb7  Growth factor receptor bound protein 7 
Hba-x  Hemoglobin X, alpha-like embryonic chain in Hba 
complex 
Hbb-y  Hemoglobin Y, beta-like embryonic chain 
Hck  Hemopoietic cell kinase 
Iapp  Islet amyloid polypeptide 
Ifitm1  Interferon induced transmembrane protein 1 
Ifitm2  Interferon induced transmembrane protein 2 
Igf2bp2  Insulin-like growth factor 2 mRNA binding protein 2 
Il6st  Interleukin 6 signal transducer 
Ins2  Insulin II 
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Kit  Kit oncogene 
Krt1  Keratin 1 
Lama1  Laminin, alpha 1 
Lamb1  Laminin B1 
Lamc1  Laminin, gamma 1 
Lefty1  Left right determination factor 1 
Lefty2  Left-right determination factor 2 
Lifr  Leukemia inhibitory factor receptor 
Lin28a  Lin-28 homolog A (C. elegans) 
Myf5  Myogenic factor 5 
Myod1  Myogenic differentiation 1 
Nanog  Nanog homeobox 
Nes  Nestin 
Neurod1  Neurogenic differentiation 1 
Nodal  Nodal 
Nog  Noggin 
Nr5a2  Nuclear receptor subfamily 5, group A, member 2 
Nr6a1  Nuclear receptor subfamily 6, group A, member 1 
Numb  Numb gene homolog (Drosophila) 
Olig2  Oligodendrocyte transcription factor 2 
Pax4  Paired box gene 4 
Pax6  Paired box gene 6 
Pdx1  Pancreatic and duodenal homeobox 1 
Pecam1  Platelet/endothelial cell adhesion molecule 1 
Podxl  Podocalyxin-like 
Pou5f1  POU domain, class 5, transcription factor 1 
Pten  Phosphatase and tensin homolog 
Ptf1a  Pancreas specific transcription factor, 1a 
Rest  RE1-silencing transcription factor 
Runx2  Runt related transcription factor 2 
Sema3a  Sema domain, immunoglobulin domain (Ig), short 
basic domain, secreted, (semaphorin) 3A 
Serpina1a  Serine (or cysteine) peptidase inhibitor, clade A, 
member 1a 
Sfrp2  Secreted frizzled-related protein 2 
Sox17  SRY-box containing gene 17 
Sox2  SRY-box containing gene 2 
Sst  Somatostatin 
Sycp3  Synaptonemal complex protein 3 
T  Brachyury 
Tat  Tyrosine aminotransferase 
Tcfcp2l1  Transcription factor CP2-like 1 
Tdgf1  Teratocarcinoma-derived growth factor 1 
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Tert  Telomerase reverse transcriptase 
Utf1  Undifferentiated embryonic cell transcription factor 1 
Wt1  Wilms tumor 1 homolog 
Zfp42  Zinc finger protein 42 
Gusb  Glucuronidase, beta 
Hprt  Hypoxanthine guanine phosphoribosyl transferase 
Hsp90ab1  Heat shock protein 90 alpha (cytosolic), class B 
member 1 
Gapdh  Glyceraldehyde-3-phosphate dehydrogenase 
Actb  Actin, beta 
MGDC  Mouse Genomic DNA Contamination 
RTC  Reverse Transcription Control 
RTC  Reverse Transcription Control 
RTC  Reverse Transcription Control 
PPC  Positive PCR Control 
PPC  Positive PCR Control 
PPC  Positive PCR Control 
 
 
 
 
 
 
 
 
 
Table 4: Genes in the Mouse Wnt Signaling Pathway 
 
Gene Symbol Gene Description 
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Aes  Amino-terminal enhancer of split 
Apc  Adenomatosis polyposis coli 
Axin1  Axin 1 
Bcl9  B-cell CLL/lymphoma 9 
Btrc  Beta-transducin repeat containing protein 
Ctnnbip1  Catenin beta interacting protein 1 
Ccnd1  Cyclin D1 
Ccnd2  Cyclin D2 
Ccnd3  Cyclin D3 
Csnk1a1  Casein kinase 1, alpha 1 
Csnk1d  Casein kinase 1, delta 
Csnk2a1  Casein kinase 2, alpha 1 polypeptide 
Ctbp1  C-terminal binding protein 1 
Ctbp2  C-terminal binding protein 2 
Ctnnb1  Catenin (cadherin associated protein), beta 1 
Daam1  Dishevelled associated activator of morphogenesis 1 
Dixdc1  DIX domain containing 1 
Dkk1  Dickkopf homolog 1 (Xenopus laevis) 
Dvl1  Dishevelled, dsh homolog 1 (Drosophila) 
Dvl2  Dishevelled 2, dsh homolog (Drosophila) 
Ep300  E1A binding protein p300 
Fbxw11  F-box and WD-40 domain protein 11 
Fbxw2  F-box and WD-40 domain protein 2 
Fbxw4  F-box and WD-40 domain protein 4 
Fgf4  Fibroblast growth factor 4 
Fosl1  Fos-like antigen 1 
Foxn1  Forkhead box N1 
Frat1  Frequently rearranged in advanced T-cell lymphomas 
Frzb  Frizzled-related protein 
Fshb  Follicle stimulating hormone beta 
Fzd1  Frizzled homolog 1 (Drosophila) 
Fzd2  Frizzled homolog 2 (Drosophila) 
Fzd3  Frizzled homolog 3 (Drosophila) 
Fzd4  Frizzled homolog 4 (Drosophila) 
Fzd5  Frizzled homolog 5 (Drosophila) 
Fzd6  Frizzled homolog 6 (Drosophila) 
Fzd7  Frizzled homolog 7 (Drosophila) 
Fzd8  Frizzled homolog 8 (Drosophila) 
Gsk3b  Glycogen synthase kinase 3 beta 
Jun  Jun oncogene 
Kremen1  Kringle containing transmembrane protein 1 
Lef1  Lymphoid enhancer binding factor 1 
Lrp5  Low density lipoprotein receptor-related protein 5 
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Lrp6  Low density lipoprotein receptor-related protein 6 
Myc  Myelocytomatosis oncogene 
Nkd1  Naked cuticle 1 homolog (Drosophila) 
Nlk  Nemo like kinase 
Pitx2  Paired-like homeodomain transcription factor 2 
Porcn  Porcupine homolog (Drosophila) 
Ppp2ca  Protein phosphatase 2 (formerly 2A), catalytic subunit, 
alpha isoform 
Ppp2r1a  Protein phosphatase 2 (formerly 2A), regulatory 
subunit A (PR 65), alpha isoform 
Ppp2r5d  Protein phosphatase 2, regulatory subunit B (B56), 
delta isoform 
Pygo1  Pygopus 1 
Rhou  Ras homolog gene family, member U 
Senp2  SUMO/sentrin specific peptidase 2 
Sfrp1  Secreted frizzled-related protein 1 
Sfrp2  Secreted frizzled-related protein 2 
Sfrp4  Secreted frizzled-related protein 4 
Slc9a3r1  Solute carrier family 9 (sodium/hydrogen exchanger), 
member 3 regulator 1 
Sox17  SRY-box containing gene 17 
T  Brachyury 
Tcf7l1  Transcription factor 7-like 1 (T-cell specific, HMG box) 
Tcf7  Transcription factor 7, T-cell specific 
Tle1  Transducin-like enhancer of split 1, homolog of 
Drosophila E(spl) 
Tle2  Transducin-like enhancer of split 2, homolog of 
Drosophila E(spl) 
Wif1  Wnt inhibitory factor 1 
Wisp1  WNT1 inducible signaling pathway protein 1 
Wnt1  Wingless-related MMTV integration site 1 
Wnt10a  Wingless related MMTV integration site 10a 
Wnt11  Wingless-related MMTV integration site 11 
Wnt16  Wingless-related MMTV integration site 16 
Wnt2  Wingless-related MMTV integration site 2 
Wnt2b  Wingless related MMTV integration site 2b 
Wnt3  Wingless-related MMTV integration site 3 
Wnt3a  Wingless-related MMTV integration site 3A 
Wnt4  Wingless-related MMTV integration site 4 
Wnt5a  Wingless-related MMTV integration site 5A 
Wnt5b  Wingless-related MMTV integration site 5B 
Wnt6  Wingless-related MMTV integration site 6 
Wnt7a  Wingless-related MMTV integration site 7A 
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Wnt7b  Wingless-related MMTV integration site 7B 
Wnt8a  Wingless-related MMTV integration site 8A 
Wnt8b  Wingless related MMTV integration site 8b 
Wnt9a  Wingless-type MMTV integration site 9A 
Gusb  Glucuronidase, beta 
Hprt  Hypoxanthine guanine phosphoribosyl transferase 
Hsp90ab1  Heat shock protein 90 alpha (cytosolic), class B 
member 1 
Gapdh  Glyceraldehyde-3-phosphate dehydrogenase 
Actb  Actin, beta 
MGDC  Mouse Genomic DNA Contamination 
RTC  Reverse Transcription Control 
RTC 
 
 Reverse Transcription Control 
RTC  Reverse Transcription Control 
PPC  Positive PCR Control 
PPC  Positive PCR Control 
PPC  Positive PCR Control 
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 To measure to effect of Dax-1 knockdown by siRNA treatment in mESC, 
optimization of varying Dax-1 siRNA concentrations and combinations was tested. 
Initial analysis of optimizations of knockdown of mDax-1 protein in siRNA treated 
mESC was confirmed by western blot analysis. Detection of mDax-1 protein was 
analyzed using antibodies specific to Dax-1. In addition, detection of the chromatin 
protein, Histone 3, was measured by western blot analysis as a measure of cell 
viability from the treatment and protein loading control. mESC were treated with 
each of the three Dax-1 specific siRNAs in single treatment at 20nM as well as all 
three Dax-1 siRNAs in combination treatment at varying concentrations for 48 
hours (Figure 7) . mESC that treated with each single Dax-1 siRNA at 20nM showed 
varying effects. The measure of Dax-1 or Histone 3 protein presence is observed as a 
immunochemical band formed upon antigen-antibody incubation. Dax-1 detection is 
observed at 54KDa. Also Dax-1A (Dax-1 splice variant) is also measurable and is 
observed at 45KDa. A strong decrease in protein expression of Dax-1 and Dax-1A 
was observed in single Dax-1 siRNA #2 (Figure 7-lane 4). With mESC that were 
treated with all three Dax-1 siRNAs in concentrations varying from 15nM-36nM, 
varying results were observed in western blot analysis. The strongest knockdown of 
the Dax-1 protein and its variant in the mESC that were treated with all three 
siRNAs at a total concentration of 36nM (Figure 7-lane 11).                                                    
 
Figure  7: Optimization of Dax-1 knockdown. To determine the precise 
concentration and experimental treatment of Dax-1 siRNA in mESC, we performed 
48 hour lipofectamide RNAiMAX transfections with three Dax-1 siRNAs in single 
treatment at a constant 20nM and in triple combination treatment at 15nM, 21nM, 
 24nM, 27nM, and 36nM. Decrease in Dax
single treatment #2 as well as triple combination treatment of 36nM compared to 
positive expression of Dax-1 in Untreated 
treated mESC. 
 
 
 
In addition, it was determined that the most efficient knockdown of Dax
mESC was by treating mESC for two 24 hour incubations. Histone 3 expression was 
-1 protein expression was observed in 
and non-targeting siRNA Stealth Control 
-
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1 protein in 
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constant across all samples, indicating no loss of cell viability with various siRNA 
treatments. 
 After the initial optimization analysis, we next sought to determine the effect 
of Dax-1 expression upon Dax-1 siRNA treatments. This was carried out by PCR 
analysis of a 336 bp region of exon 2 in the mouse Dax-1 gene which is 
representative of the presence of Dax-1 mRNA transcript in mouse embryonic stem 
cells. Following PCR, samples were analyzed by DNA agarose gel electrophoresis 
and the intensity level of each band of cDNA as measured by the GelDoc software is 
proportional to the expression of mDax-1 mRNA transcript in treated mouse 
embryonic stem cell cDNA samples. In the cDNA samples that were extracted from 
mESC siRNA treatment for Dax-1, expression of Dax-1 transcript was decreased in 
the samples treated with 36nM and 45nM concentrations (Figure 8.A-lane 4 and 5) 
of all three siRNAs targeting the transcript of Dax-1 compared to positive detection 
of mDax-1 observed in mESC samples that were either untreated, transfected with 
reagent only, or treated with a non-targeting siRNA (Figure 8.A-lane 1-3). Upon 
siRNA treatment specific for Dax-1, expression of Dax-1 was greatly diminished 
compared to a GAPDH control (Figure 8.A). The results of Dax-1 knockdown were 
quantitatively confirmed by qPCR analysis of cDNA samples for the mDax-1 gene 
compared against the house keeping gene GAPDH as a control.                                      
 
  
Figure 8: Analysis of Dax-
mRNA transcript and protein
transfections were performed. After treatment, mRNA was collected to synthesize 
DNA for PCR analysis and protein lysates were collected for Western Blot analysis in 
knockdown determination. 
highly expressed in Untreated, transfection reagent only treated, and non
siRNA Stealth Control treated mESC. mESC that were treated with triple 
combination of Dax-1 siRNA at 36nM and 45nM showed decrease of Dax
expression indicating knockdown of the Dax
constant in all samples . B.)
45nM triple siDax-1 treated quantitatively confirmed the results of regular PCR 
indicating that mDax-1 expression is decreased. qPCR results were also compared 
against expression of mGapdh as a control. 
the Dax-1 protein is down-regulated due to triple siDax
expression remains constant
treated, and Stealth control treated mESC. These results of protein expression were 
compared to the protein, Beta
samples. 
1 knockdown in mESC. To efficiently knockdown Dax
 levels, 2 x 24 hour lipofectamide RNAiMAX 
A.) PCR analysis of mDax-1 indicated that Dax
-1 transcript. mGapdh expression was 
 qPCR analysis of Untreated, Stealth Control, 36nM and 
C.) Western Blot analysis confirms that 
-1 treatment. Dax
 in all positive control samples Untreated, Reagent only 
-Actin, which was consistently expressed in all 
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Compared to qPCR measured relative expression of untreated mESC, expression of 
mDax-1 was down regulated by 38% in samples treated with 36nM mDax-1 siRNA 
and down-regulated by 88% in mESCs treated with 45nM mDax-1 siRNA (Figure 
8.B-lanes 3-4). mDax-1 expression was minimally decreased in the non targeting 
stealth control treated mESC with a 8% down regulation of expression (Figure 8.B-
lanes 1-2). qPCR results were performed and analyzed in triplicate, and each sample 
was normalized to the relative expression of the house keeping gene, GAPDH. 
Finally, knockdown of mDax-1 protein levels by siRNA treated mESC was confirmed 
by western blot analysis. Presence of a immunochemical band for Dax-1 was 
observed in untreated, transfection reagent only treated, and non-targeting siRNA 
treated mESC samples (Figure 8.C-lanes 1-3).  However, a decrease in 
immunochemical bands were detected in mESC samples treated with 36nM and 
45nM siRNA for mDax-1  (Figure 8.C-lanes 4-5), which  is indicative of Dax-1 
knockdown. 
 As Dax-1’s role in a developmental context is not well understood, determining 
the genes that are targeted by Dax-1 in early embryonic development is key to 
elucidating this role. To specifically investigate which genes in embryonic stem cell 
signaling are targeted by Dax-1, I utilized RT-qPCR microarray methodology, which 
allowed me to screen 84 different genes in diverse embryonic stem cell signaling 
pathways (Figure 9). Focusing on the embryonic pathways that when activated 
result in cellular fate determination and differentiation, mRNA from stealth control 
non-targeting siRNA treated mESC and mDax-1 siRNA treated mESC were harvested 
for cDNA synthesis.                                                                                                                        
  
Figure 9: SAbiosciences RT
for testing gene expression profile for Non
vs 45nM siDax-1 treated mESC. Stem Cells were transfected with non
siRNA for Dax-1 for a total of 48
was performed, and RT-qPCR was run before analyzing results of gene fold up or 
down regulation in response to knockdown of Dax
http://www.sabiosciences.com/pathway7.php#pcrHow
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46
 47
After cDNA synthesis, microarrays analysis was performed and results comparing 
genes that were effected by Dax-1 siRNA knockdown in mESC to off-target effects 
inherent from the transfection treatment of mESC, were analyzed.  
 Using algormithmic technology from the SA biosciences website, averages of 
the RT-qPCR array results from the non targeting siRNA treated mESC were 
analyzed and compared to RT-qPCR array results of the Dax-1 siRNA treated mESC 
(Figure 10). Genes involved in ESC signaling that expressed a fold change of greater 
than 1 can be said to be up-regulated, and genes that expressed a fold change of 
greater than -1 can be said to be down-regulated. Many genes involved in embryonic 
stem cell signaling were affected by Dax-1 knockdown in mouse embryonic stem 
cells. After analysis, broad observations showed that genes that were involved in 
self-renewal and maintenance of pluripotency were down-regulated while genes 
that drive differentiation towards several fated lineages were up-regulated, 
especially genes that drive cell fates from mesoderm derived tissue (Table 5).  
 In further using SA biosciences analysis technology, we observed that, upon 
Dax-1 knockdown in mESC, several genes had a fold regulation increase of 1 
indicating significant interest of gene as a potential target of Dax-1.  Further, our 
findings show that in mouse ESC  the gene products for Afp, Ddx4,  Ednrb, Flt1, 
Foxa2, Gata6, Nr5a2, Ptf1a, and Sox17 were all modestly increased by a fold up-
regulation of 2 while gene products for Gbx2, Hba-x, Ins2, Lamc1, Lefty2, Sst, and T 
(Brachyury) all were significantly increased by a fold-upregulation of greater than 4 
(Table 5).                                                                                                                                              
 Figure 10: RT-qPCR mESC signaling array S. Cntl vs siDax-1 mESC
48
 
 49
Table 5: Profile of Candidate Target Genes in mouse Embryonic Stem Cell 
Signaling Pathway affected by the knockdown of Dax-1 in mESC. 
 
Gene Fold Change Function 
Afp 2.54 Plasma Protein produced by 
fetal Liver 
Ddx4 2.41 Germ Cell Transcription 
Factor 
Ednrb 2.15 GPCR that drives cell 
proliferation 
Flt1 2.02 RTK involved in signaling of 
endothelial cells 
Foxa2 2.16 Transcription factor that drives 
differentiation and cell fate 
Gbx2 4.67 Transcription factor expressed 
during mammalian gastrulation 
Gata6 2.41 Transcription factor that drives 
differentiation and 
organogenesis 
Nanog -2.21 Transcription factor that drives 
pluripotency and self-renewal 
Nr5a2 1.54 Orphan NHR that functions in 
regulating embryonic 
development and 
steriodogenesis 
Sox-17 2.43 Transcription factor that drives 
differentiation and cell fate 
Sox-2 -2.16 Transcription factor that 
functions in maintaining stem 
cells 
T-Brachyury 4.83 Transcription factor that drives 
mesoderm differentiation 
Hba-x 6.25 Plasma Protein produced with 
RBC 
Ins2 3.05 Hormone that stimulates 
glucose uptake 
Lamc1 5 Extracellular glycoprotein that 
mediates cell attachment, 
migration, and organization 
during embryonic development 
Lefty2 8.23 TGF- signaling protein that 
determines Left-Right 
symmetry in organogensis 
Sst 6.04 Hormone that regulates 
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neurogenesis  
Gcg -2.10 Hormone that enhances 
glucose metabolism 
Gdf3 -2.11 BMP/ TGF- Signaling factor 
that regulates cell proliferation 
Pou5f1 -2.26 Transcription factor that drives 
pluripotency and self-renewal 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 51
Our findings also show that, upon Dax-1 knockdown in mouse ESC, the gene 
products for Gcg, Gdf3, Nanog, Pou5f1, and Sox2 all had a modest fold down 
regulation of -2.  
 To confirm results from the RT-qPCR array experiment, follow up by standard 
PCR analysis was performed. Using primers to amplify differentiation markers that 
were above a fold regulation increase of 1 or more, gene products for Afp, Foxa2, 
Gbx2, Gata6, Sox17, and T-Brachyury were analyzed. In follow up PCR analysis, we 
observed a significant qualitative increase in expression of A.) Afp B.) Gata6 C.) T-
Brachyury D.)Gbx2  in mESC that were treated with 45nM of siRNA targeting Dax-1 
and compared expression to the house keeping gene G.)GAPDH, which remained 
constant in all samples (Figure 11. A-D & G). There was also a modest increase in 
expression of the aforementioned gene products in mESC treated with 36nM siDax-
1 compared to the Dax-1 positive untreated and treated mESC. I further confirmed 
differentiation of mESC upon siRNA knockdown of Dax-1 in performing PCR analysis 
to measure the expression of pluripotency markers. I observed a qualitative 
decrease in expression of  E.) Sox2 and F.) Nanog in mESC that were treated with 
36nM and 45nM of siDax-1 compared to untreated, Lipofectamine treated, and non-
targeting treated mESC while the expression of G.) GAPDH remained consistently 
expressed in all mESC samples (Figure 11. E-G).  It can also be observed by 
microscopy that, following Dax-1 siRNA treatment, cells transform from 
morphology that is characteristic of pluripotent cells to morphology consistent with 
differentiated mouse stem cells (Figure 12).  
  
 
 
 
 
 
 
 
 
Figure 11: PCR analysis of Candidate Target Genes of Dax
the effect of Dax-1 knockdown on gene targets demonstrated that genes involved in 
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mGata6, C.) mT-Brachyury, and D.)Gbx2, were up
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Figure 12: Morphological Change of mESC
pluripotent embryonic stem cells and notes their morphological change as they 
differentiate. In culture, the enlarged fibroblast
differentiated, will form into a differentiated cellular mass called an embryo
The signaling factors that regulate this transition are currently under investigation.
B. Upon treatment of 45nM siDax
morphological fibroblastic phenotype to an aggregated cellular mass similar to an 
embryoid body, which is indicative of differentiation. The signaling factors that 
control Dax-1 in mESC to maintain pluripotency are previously unexplored. 
(Reference Image used from 
iPhone camera and Tissue Culture Microscope)
A. 
B. 
. A. This image depicts undifferentiated, 
-like embryonic stem cell, once 
-1, Untreated, pluripotent, mESC change their 
http://ars.els-cdn.com and image captured from 
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id body. 
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Discussion  
Chapter 1: Loss of Pluripotency by Dax-1 knockdown 
 In this research, Dax-1 knock down was performed to identify target genes of 
Dax-1 in mouse embryonic stem cell signaling. Dax-1, an orphan nuclear receptor, 
functions as a negative transcriptional regulator. In adult mammals, Dax-1’s 
expression pattern is well-characterized to regulating steroidogenic pathways in the 
hypothalamic-pituitary-adrenal-gonadal axis. However, over the past decade, a new 
role for Dax-1 has been elucidated. Preliminary studies have shown that upon 
targeted knockdown of Dax-1, pluripotent stem cells in culture begin to differentiate 
(Niakan 2005). In this study, I was able to confirm that upon knockdown of Dax-1 in 
mESC, differentiation of pluripotent stem cells occurs. I validated this data by 
performing a gene profile of experimental and control treated stem cells through 
RT-qPCR array analysis of genes in the embryonic stem cell signaling pathway. As I 
hypothesized, genes that that are activated upon stem cell differentiation were 
found to be up-regulated upon the absence of Dax-1 and genes that maintain 
pluripotency were found to be down-regulated. In initial targeting, I found that Afp, 
Foxa2, Gata6, and T brachyury were all up-regulated and Nanog, Oct3/4, and Sox2 
were all found to be down regulated upon the knockdown of Dax-1 in mESC. The 
degrees of up-regulation and down-regulation varied among the targets identified, 
but all targets pursued were seen as potentially interacting with Dax-1 as 
pluripotent factors or regulated by transcriptional control and these differentiation 
factors were repressed by Dax-1.  
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 As a method to confirm loss of pluripotency upon knockdown of Dax-1, 
analysis of pluripotency markers were performed. Nanog, Oct3/4, and Sox2 are all 
major known regulators of pluripotency in ESC and early embryonic development. 
These transcription factors function by binding to DNA elements to either drive 
pluripotency factors or repress differentiation factors  (Loh 2006). By analyzing 
these targets in this study, I was able to confirm the loss of pluripotency in mESC 
when these factors are down regulated. Nanog and Oct3/4 have previously been 
shown to interact and include Dax-1 in known pluripotency networks. It is likely 
that Dax-1 and Nanog, Oct3/4, or Sox2 all directly associate through protein-protein 
interactions to maintain pluripotency by repressing target genes that would drive 
differentiation (Loh 2006 and Rizzino 2009). 
 Differentiation gene targets isolated from the gene profile have all been shown 
to be key markers of differentiation in mammalian development. Upon gastrulation, 
cells of the ICM of the blastocyst begin to migrate and further develop from 
precursor tissue layers of the mass into three primary embryonic tissue layers: 
ectoderm, mesoderm, and endoderm. Mesoderm tissue ultimately develops into cell 
layers of many vital organs such as the pancreas, liver, and adrenals (Gilbert 2006). 
Gene target analysis shows that T-brachyury was up-regulated by a fold-up 
regulation of above 4. This target is a very well established marker of mesoderm 
differentiation. Since Dax-1 regulates the maintenance of many steroidogenic 
tissues (ultimately developed from mesoderm),  it is very interesting because it 
appears that down regulation of Dax-1, in a developmental context, drives further 
development of many mesoderm derived tissue. This data hints that Dax-1 regulates 
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the development of this tissue, eventually is turned off once the signal for 
differentiation has occurred, and selectively turns back on to regulate the 
production of many steroidogenic tissues.  
 Furthermore, the differentiation markers Afp, Foxa2, and Gata6 have all been 
implicated to be up-regulated upon the differentiation of tissue destined to become 
pancreatic or liver from such primordial mesoderm tissue. Notably, Dax-1 has been 
shown to interact with another key transcriptional regulator, LRH-1, that has been 
shown to target these genes also in its regulational role of pluripotency (Wagner 
2010). The known interaction of LRH-1 and Dax-1 might provide insight as to how 
Dax-1 and LRH-1 cooperate to transcriptionally repress the target genes: T-
Brachyury, Foxa2, Gata6, and Afp, that when appropriately expressed will drive 
differentiation from primordial stem cell layers.  
 In depriving stem cells in culture of Dax-1 expression, I was able to examine 
the role of Dax-1 in early embryonic development. Early in vivo analysis  has been 
implicated Dax-1 to be highly expressed from 2.5-7.5 days after fertilization in early 
mouse embryonic stem cell cleavages when primordial stem cell layers are 
proliferating and developing. During this time, cells of these early cleavages all 
retain the capability to differentiate into any cell type. What remains in question is 
the mechanism as to how cells of these early cleavages control their proliferation to 
retain their pluripotent capability and further, which signals keep stem cells of early 
cleavages from differentiating at inappropriate times. These mechanistic questions 
remain not fully answered and still are an exciting area of stem cell research.  
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Introduction II 
Chapter 2: Major Signaling Events in Development 
 Signaling required to maintain pluripotency 
 The ability for cells in early embryonic development to communicate with one 
another is often carried out by signaling that occurs from one cell to another. Often 
in a paracrine fashion, the secretion of growth factors, small peptide/glycoprotein 
molecules, and lipids are often key for inducing and specifying cells to differentiate 
to a determined fate (Glibert 2006). The secretion of these factors is a highly 
regulated process, and is essential for normal embryonic development. In most 
cases, even a small concentration of any of these signaling molecules will have 
dramatic effects on a developing embryo. Over the past decade, great advancements 
in stem cell biology research have been made indicating that there is not a sole 
signaling pathway that controls and regulates developmental decisions of early 
embryonic development. Rather, it has been shown through embryological 
experiments that there are multiple signaling pathways responsible for regulating 
and maintaining stem cell self-renewal (Chambers 2004).  
 In the formation of the ICM during early embryonic cleavages, signal 
transduction is occurring from the LIF/STAT3, BMP/SMAD, Growth Factor-activated 
PI3K and MAPK, and the Wnt/Beta-Catenin signaling pathways, which all have been 
shown to have cascades that have influences on maintaining the cellular process of 
self-renewal (Figure 16) (Okita 2006).                                                                                   
  
Figure 13: Intracellular Signaling Pathways involved in Stem Cell Self
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-renewal. 
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While the precise mechanism of how these signaling pathways mediate self-renewal 
in early mammalian embryonic development remains elusive, it is thought that 
much downstream cross-talk occurs in the intracellular cascades of these pathways 
that ultimately has an effect on several key self-renewal transcription factors such 
as Oct3/4 and Nanog (Okita 2006). It is likely that these pathways were retained 
through evolution as redundant mechanisms to precisely regulate early embryonic 
development.  
 Of the major signaling pathways, the Wnt signaling pathway is unique in its 
own light because of the shear number of secreted molecules that activates this 
pathway that have a multitude of functions during embryonic development 
including the maintenance of stem cell self-renewal. Of the 19 mammalian secreted 
glycoproteins in the Wnt signaling family, Wnt 4 has been shown to have a key role 
in regulating the development of early gonadal and steroidogenic tissue (Richards 
2002). The disruption of its expression in early embryonic development through 
mutational analysis leads to phenotypes of gonadal and adrenal dysgenesis. Further, 
the over-expression and misregulation of Wnt4 in early embryonic development 
leads to a sex reversal phenotype that is similar to the phenotype seen when the 
nuclear hormone receptor Dax-1 is also over-expressed due to the overactive 
transcriptional efforts of beta-catenin (Jordan 2001). 
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Dax-1 expression controlled by Wnt Signaling 
 In adult steroidogenic tissue, Dax-1 has a well-defined role in regulating the 
production of steroid hormones. However, the precise mechanism of Dax-1 
activation remains unclear (McCabe Review 2006). In sertoli cells, molecular 
evidence indicates that Wnt4 positively regulates Dax-1 through beta-catenin 
transcriptional activation of the Dax-1 promoter (Jordan 2001).  
 As the Wnt signaling pathway has many diverse cellular effects during 
development, Wnt4 has been shown to have antagonistic effects during sex 
determination. Once Wnt4 is secreted extracellularly, often in paracrine fashion, it’s 
signal is transduced through a family of serpentine G protein-coupled receptors 
called the Frizzed receptors family, which has many cascading effects on a targeted 
cell. In canonical Wnt signaling, activation of Frizzled by Wnt leads to hyper-
phosphorylation of the cytoplasmic protein Dishevelled. This then leads to 
inactivation of glycogen synthase kinase 3B complexing with APC, a complex that 
without Wnt signaling at the surface leads to phosphorylation, ubiquitination, and 
destruction of beta catenin via the proteosome. By inactivating the destruction 
complex through Wnt signaling, Beta-Catenin is not destroyed and is free to function 
in the cytosol as well as the nucleus as a transcriptional regulator (Richards 2002). 
 Through multiple experiments, it was observed that when Wnt4 is over-
expressed in steroidogenic tissue, Dax-1 is highly expressed. Validated observations 
and immunochemical staining show that the high proteins levels of Dax-1 were 
maintained by Wnt4 signaling independent of SF-1 regulation, a known positive 
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regulator of Dax-1. When Wnt4 signaling is shut off, via regulative inhibition of the 
Wnt signaling pathway through the protein Dickopff, Dax-1 expression is 
maintained when SF-1 is present in this regulative context. However, if both Wnt4 
signaling and SF-1 are absent in steroidogenic sertoli cells, Dax-1 expression is lost 
(Jordan 2001). These outcomes are validated through mice models that present 
dosage sensitive sex reversal phenotypes upon Dax-1, Wnt4, SRY, or SF-1 over-
expression (Harley 2004). It is apparent that Dax-1 is affected by Wnt4 signaling in 
steroidogenic cells; however, it remains a question as to whether or not Wnt4 
signaling regulates Dax-1 in a developmental context.  
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Research Proposal II 
 In this chapter, I will explore further Dax-1’s role in the Wnt Signaling 
pathway. Similar to Dax-1, the Wnt signaling pathway is known to be physiologically 
active during embryogenesis and steroidogenesis. Over the past decade, many 
guiding experiments performed by Richards and Jordan (Jordan 2001) have hinted 
to the connection between the Wnt signaling pathway and Dax-1 function. In 
determining how Dax-1 in embryonic stem cells may be regulated, it follows logic to 
analyze whether or not the Wnt signaling pathway is affected by loss of pluripotency 
by Dax-1 knockdown in mouse embryonic stem cells. It is possible that the major 
effector of the Wnt signaling pathway, beta-catenin, may also interact with Dax-1 as 
there is previous evidence as aforementioned that beta-catenin is known to interact 
with many nuclear hormone receptors, such as LRH-1, in the process of forming 
large transcriptional complexes. To determine a mechanistic role for Dax-1 in 
maintaining transcriptional control of embryonic stem cell pluripotency in mouse 
ESC, investigation of multiple components in the Wnt signaling pathway will be 
pursued. 
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Methods and Materials II 
Protein Isolation 
Whole cell protein lysate was collected following 48 hour siRNA transfection using 
NP-40 cellular lysis buffer (Boston Bioproducts, Worcester, MA) with 1:100 Halt 
Protease Inhibitor (New England Biolabs, Ipswich, MA). Directed addition of lysis 
buffer was applied to wells for protein collection in 12-well plate format, rocked 
with minor agitation (150 RPM) at 4°C for 15 minutes. Samples were then scrapped 
using a cell scrapper, collected, and transferred to a 1.5mL microcentrifuge tube and 
centrifuged at 14,000g for 10 minutes. The supernantant was then transferred to a 
new, clean and labeled 1.5mL microcentrifuge tube and stored at -70°C for future 
western blot and co-immunoprecipitation analysis.  
Western Blot 
Western blot analysis was performed according to the NuPAGE Novex Bis-Tris 
protocol (Invitrogen, Carlsbad, CA). Ten micrograms of each isolated protein sample 
was added with 4X NuPAGE LDS sample loading bugger, 10X NuPAGE reducing 
agent and deionized water to bring up a total volume of 15uL. 4-12% Bis-Tris SDS-
PAGE gels were run using the XCell II Blot Module (Invitrogen, Carlsbad, CA) at 200V 
for 45 minutes. After electrophoresis, gel was sandwiched with PVDF membrane 
and filter papers/sponges according to Manufacturer's protocol. Blot transfer was 
carried out with the XCell II Blot Module Western Blot apparatus and ran at 25V for 
1 hour. Following transfer, membrane was blocked in 5% Blotto rocking at 150 RPM 
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for 1 hour and then incubated overnight in 4°C with 5% Blotto with primary 
antibody (Santa Cruz and Cell Signaling Technologies, Santa Cruz, CA) in a 1:1000 
solution rocking at 150 RPM.  After overnight primary incubation, blots were 
washed three times in 15mL TBST for five minute washes rocking at 150RPM in 
room temperature. The blots were then incubated with HRP-conjugated secondary 
antibody to either rabbit or mouse IgG at 1:2000 in 5% Blotto solution for 2 hours at 
room temperature (BD Pharmingen, San Diego, CA). Blots were then again washed 
three times in 15mL TBST for five minute washes rocking at 150RPM in room 
temperature. Lastly, 1 mL of Chemiluminescent Substrate (Thermo Scientific, 
Rockford, IL) was added to each blot and were then wrapped in saran wrap for 
development. Blots were then exposed using the GelDoc system (BioRad Hercules, 
CA) and photographed at regular intervals for 10 minutes. 
Co-Immunoprecipitation 
Direct protein-protein interactions between Dax-1 and beta-catenin was observed 
using the Dynabeads Protein G co-immunoprecipitation kit (Invitrogen, Carlsbad, 
CA). Using 50 microliters of magnetic dynabeads coupled to protein G, further 
coupling of an antibody to protein G is possible for pull down analysis. The binding 
of the IgG portion of a monoclonal antibody to beta-catenin allows for direct 
pulldown of beta-catenin when either untreated, stealth control treated mESC, or 
siDax-1 mESC protein lysate was run over the dynabead + protein G + beta-catenin 
antibody complex. Once the lysate has been allowed to run over the complex and the 
antigen, beta-catenin, has had sufficient time to bind to its specific monoclonal 
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antibody, three washes are performed using washing buffer to wash any non-
specific binding to the beta-catenin antibody. The coupled complex of dynabeads + 
antibody + antigen was then eluted into an microcentrifuge tube using Elution 
Buffer (Invitrogen, Carlsbad, CA). Further western blot analysis was performed on 
eluted sample to analyze whether other protein components directly bound and 
interacting with beta-catenin were pulled down as well, such as Dax-1. 
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Results II 
 Hints of Dax-1 regulation by Wnt signaling has been evident over the past 
decade. Recent studies have shown that, in a steriodogenic context, Wnt signaling 
positively regulates Dax-1.  The role of Wnt signaling  in a developmental context is 
not well understood. Therefore, determining the genes that are targeted by Dax-1 in 
the Wnt signaling pathway in early embryonic development is key to elucidating 
this mechanism. To specifically investigate the genes in Wnt signaling pathway are 
targeted by Dax-1, I utilized a RT-qPCR microarray containing primers for 84 
different genes in the mouse Wnt signaling pathways (Figure 12). Focusing on the 
Wnt pathways that when activated result in cellular fate determination and 
differentiation, mRNA from stealth control non-targeting siRNA treated mESC and 
mDax-1 siRNA treated mESC were harvested for cDNA synthesis and used to screen 
genes in the mouse Wnt Signaling RT-qPCR array.  
 Using algormithmic technology from the SA biosciences website, averages of 
the Wnt RT-qPCR array results from the non targeting siRNA treated mESC were 
analyzed and compared to Wnt RT-qPCR array results of the Dax-1 siRNA treated 
mESC (Figure 17).  Many genes involved in Wnt signaling were affected by Dax-1 
knockdown in mouse embryonic stem cells, and after analysis, broad observations 
showed that genes that were involved in secretion of Wnt signaling molecules were 
down-regulated while genes that drive cell proliferation towards several fated 
lineages were up-regulated (Table 6).  
 
  Figure 14: RT-qPCR Wnt signaling array S. Cntl vs siDax-1 mESC
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Table 6: Profile of Candidate Target Genes in Wnt Signaling Pathway 
affected by the knockdown of Dax-1 in mESC. 
Gene Fold Change Function 
Ccnd1 2.71 Cell Cycle Regulator 
Ccnd2 2.31 Cell Cycle Regulator 
Ccnd3 2.45 Cell Cycle Regulator 
Sfrp1 2.38 Secreted signaling factor that 
inhibits Wnt/-catenin signaling 
Sfrp2 2.72 Secreted signaling factor that 
inhibits Wnt/-catenin signaling 
Frzb 2.99 Soluble signaling factor that 
regulates Wnt/ β -catenin 
signaling 
Sfrp4 2.12 Secreted signaling factor that 
inhibits Wnt/ β -catenin signaling 
Sox17 2.11 Transcription factor that drives 
differentiation and cell fate 
T-Brachyury 2.06 Transcription factor that drives 
mesoderm differentiation 
Axin1 -2.6 Intracellular regulator of Wnt/ β -
catenin signaling 
Dvl1 -2.51 Intracellular regulator of Wnt/ β -
catenin signaling 
Dvl2 -3.49 Intracellular regulator of Wnt/ β -
catenin signaling 
Frat1 -3.75 Intracellular inhibitor of GSK-3 β  
in Wnt/ β -catenin signaling 
Tle2 -2.56 Transcription factor that inhibits 
differentiation 
Wisp1 -2.79 Growth Factor that induces 
Wnt/ β -catenin signaling  
Wnt4 -7.34 Secreted signaling protein that 
activates Wnt/ β -catenin signaling  
Wnt6 -3.48 Secreted signaling protein that 
activates Wnt/ β -catenin signaling  
Wnt7a -5.39 Secreted signaling protein that 
activates Wnt/ β -catenin signaling  
Wnt8a -2.45 Secreted signaling protein that 
activates Wnt/ β -catenin signaling  
 Moreover, in using SA biosciences analysis technology, we observed that, upon 
Dax-1 knockdown in mESC, several genes had a fold regulation increase of 1 
indicating significant interest of gene as a potential target of Dax-1.  My results 
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indicate that in mouse ESC  the gene products for Ccnd1, Ccnd2, Ccnd3, Sfrp1, Sfrp2, 
Frzb, Sfrp4, Sox17, and T brachyury were all modestly increased by a fold up-
regulation of 2 correlating data seen from the RT-qPCR array investigating genes 
involved in differentiation (Table 6). It was also found that upon Dax-1 knockdown 
in mouse ESC, the gene products for Axin1, Dvl1, Dvl2, Frat1, Tle2, Wisp1, Wnt6, 
Wnt7a, Wnt8a all had a modest fold down regulation of between -2 and -5 in the 
experimental samples that were treated with siDax-1 compared to the non targeting 
stealth control treated mESC. It is particularly interesting to highlight that Wnt4 had 
a fold down regulation of -7, which is particularly intriguing and significant (Table 
6).  
 To further investigate whether the knockdown of Dax-1 in mouse ESC affects 
the Wnt signaling pathway, western blot analysis using antibodies against several 
key proteins within the Wnt signaling pathway was performed. Positive Wnt 
signaling leads to excess of beta-catenin, which leads to overall transcriptional 
changes. I observed several key changes to the protein level expression of Wnt 
pathway following Dax-1 knockdown in the mESC (Figure 18). Upon treating mESC 
with either 36nM or 45nM Dax-1 siRNA, down regulation of the Wnt effector 
molecule, beta-catenin, occurred (Figure 18-lanes 4-5). Further, I observed that 
while there was less total beta-catenin present in the mESC samples treated with 
siDax-1 due to a higher degree of phosphorylation of beta-catenin at amino acid 
residues Serine 33/35 (Figure 18-lanes 4-5).  This modification event leads to 
degradation of beta-catenin. In mESC samples were Dax-1 expression is maintained, 
such as untreated, transfection reagent only, and non-targeting siRNA treated mESC, 
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expression of total beta-catenin remains strong while the degree of phosphorylation 
of beta-catenin in these samples in minimal (Figure 18-lanes 1-3). Moreover, GSK-
3, the kinase that specifically phosphorylates beta-catenin in mESC, is also affected 
by Dax-1 knockdown. Analysis of phosphorylated GSK-3 indicated that, upon 
siDax-1 treatment of mESC, less phosphorylated GSK-3 was present (Figure 18-
lanes 4-5), while more phosphorylated GSK-3B is present when the mESC are 
positive for Dax-1 (Figure 18-lanes 1-3). In analyzing beta-actin as a control, 
western blot analysis verified that levels of the cytoskeletal protein remained 
constant in all samples. 
 Finally, to correlate data observed in western blot analysis, investigation into 
the possibility of direct interaction between Dax-1 and beta-catenin was sought. 
Through co-immunoprecipitation assays, antibodies to beta-catenin were used to 
isolate beta-catenin containing other complexes from mESC (Figure 19). The 
immunoprecipitation was followed by western blot analysis using Dax-1 specific 
antibody. I found that Dax-1 was detected in those samples where beta-catenin was 
used to specifically to immunoprecipitate protein complexes (Figure 19- lane1-2).  
This protein-protein interaction was observed at 80kDa, around the molecular 
weight of beta-catenin, in untreated and stealth control treated mESC. In mESC that 
were treated with siRNA for Dax-1 at 45nM concentration, this physical interaction 
was lost (Figure 19- lane 3). This assay was performed using an IgG antibody in all 
three mESC samples as a control, and neither beta-catenin nor Dax-1 were observed 
to be pulled down by the IgG antibody (Figure 19- lane 4-6). This validates the 
protein-protein interaction between Dax-1 and beta-catenin in pluripotent mESC. 
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Figure 15: Protein-Protein Interaction of Dax
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Discussion II 
Chapter 2: Dax-1 knockdown alters the Wnt Signaling Pathway in mESC 
 As many signaling pathways regulate development, very little is known about 
the pathways that regulate Dax-1 expression in early embryonic development. In my 
thesis research project, I sought to further elucidate the signaling factors that 
regulate Dax-1 expression. Because many of the target genes that were affected by 
Dax-1 knockdown are known targets of the Wnt signaling pathway, investigation of 
this pathway was pursued as a potentially involved in the regulation of Dax-1 in 
mouse Embryonic Stem Cells.  
 Upon knockdown of Dax-1 in mESC, several alterations to the Wnt signaling 
pathway as well as the targets genes of this pathway were observed. By performing 
a gene profile RT-qPCR array analysis of genes in the Wnt Signaling Pathway, 
determination of how Dax-1 fits into this pathway was possible. Several modest up-
regulations of the cell cycle control genes Ccnd1, Ccnd2, Ccnd3, which encodes 
Cyclin D1, Cyclin D2, and Cyclin D3, respectively were identified. In previous 
experiments in the Tzagarakis-Foster lab, it has been determined that Dax-1 
represses CyclinD1 expression through its interaction with active Estrogen Receptor 
(ER) in Breast Epithelial cell lines. By repressing CyclinD1, Dax-1 is able to further 
serve as a cell cycle brake and prevent uncontrolled cell proliferation through ER 
transcriptional activation.  Given this previous data, it correlates well with 
observations of this thesis that Dax-1 regulates the production of CyclinD to 
maintain cell cycle control in self-renewing stem cells. It appears that, as Dax-1 is 
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knocked down, these genes are up-regulated and are able to further drive cell 
division and differentiation.  
 Several genes that encode for signaling factors were also affected by the 
absence of Dax-1 in mESC. Many genes encoding the secreted Wnt signaling factors 
were down regulated when Dax-1 was knocked down in mESC. Wnt signaling, 
regardless of which Wnt isotype, results in the targeting of the pathway’s effector 
molecule beta-catenin. It has been observed that down-regulation of beta-catenin is 
necessary for proper differentiation of endoderm and mesoderm (Zorn 2007).  
These observations are consistent with my data, that upon loss of pluripotency 
through Dax-1 knockdown, multiple Wnts are down-regulated. This results in 
repression of beta-catenin in mESC to allow for differentiation. The Wnts that were 
observed to be down-regulated were Wnt1, Wnt2b, Wnt4, Wnt6, Wnt7a, Wnt7b, 
Wnt8a, Wnt8b, and Wnt9a. As it was also observed that several inhibitory factors of 
Wnt signaling were found to be modestly up-regulated upon knockdown of Dax-1, 
such as Sfrp1, Sfrp2, Frzb, and Sfrp4, to potentially further quiet this pathway as 
these factors are known regulative inhibitors to Wnt signaling. A particularly 
intriguing result from this array was that Wnt4 was significantly down-regulated 
below a down fold regulation of 7. This is significant because in steroidogenic tissue, 
it has been shown that Wnt4 positively up-regulates Dax-1 (Jordan 2001). Wnt4’s 
regulative capabilities have not been fully investigated in early embryonic 
development, but with such a significant decrease in the output of Wnt4 upon loss of 
pluripotency by Dax-1 knockdown, it is likely that there is connection to Dax-1 and 
Wnt4 in both steroidogenic and developmental contexts.  
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 To further investigate how Dax-1 knockdown altered the Wnt signaling 
pathway in mouse embryonic stem cells, we analyzed several major signaling 
components of the pathway. Western Blot analysis indicated that beta-catenin 
expression decreased with the loss of pluripotency. A greater degree of beta-catenin 
turn over and degradation in mESC was observed in cells that were treated with 
siDax-1 as well as a greater degree of phosphorylation of beta catenin in these 
samples. Therefore, it is likely that loss of Dax-1 and beta-catenin results in further 
driving differentiation events.  A detailed analysis of components of the Wnt 
Signaling pathway affected by Dax-1 knockdown has not previously been pursued. It 
is unknown as to whether or not Wnt signaling directly modifies the Dax-1 protein, 
but post-translational modifications of nuclear hormone receptors is not 
uncommon. Hence, it is entirely possible that the signaling components in the Wnt 
pathway directly affects the Dax-1 protein possibly by phosphorylation and this 
interaction is disrupted upon the knockdown of Dax-1. 
 To further decipher how Dax-1 may fit into the Wnt signaling pathway, I 
sought to investigate the possibility of interaction between Dax-1 and the Wnt 
effector molecule beta-catenin. Through co-immunoprecipitation assays, it was 
determined that beta-catenin interacts with Dax-1 in untreated and stealth control 
treated mESCs, and this interaction is lost when Dax-1 is knocked down. By pulling 
down Dax-1 bound to beta-catenin in the positive control Dax-1 expressing 
untreated and stealth control treated mESC, it can be concluded that these two 
transcription factors interact in pluripotent stem cells. Dax-1 functions in this 
context as a transcriptional co-regulator when it binds to transcription factors such 
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as Estrogen Receptor that is bound to DNA response elements and represses its 
transcriptional activation (Treuter 2012). It is entirely possible that Dax-1 can 
extend this function to other transcription factors, such as beta-catenin. One 
proposed mechanism of how Dax-1 functions to transcriptionally regulate 
pluripotency is that Dax-1 binds to beta-catenin and regulates which pluripotency 
genes will be activated. Once the appropriate fate signal is received, the stem cells 
differentiate, lose Dax-1 expression, and thereby lose this interaction of Dax-1 and 
beta-catenin as the stem cells drive on towards their fate. These details observed 
provide further insight into how Dax-1 functions in pluripotent stem cells, and 
hopefully will shed further light in elucidating the complexity of pluripotency in 
early embryonic development.  
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